Poland· PL-100059384
Sal Ems factitium
A medicinal product containing preparat złożony, registered in Poland by Przedsiębiorstwo Farmaceutyczne Ziołolek Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Preparat złożony
- Manufacturer
- Przedsiębiorstwo Farmaceutyczne Ziołolek Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990202515
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d72f27a0-dbad-44f6-860a-c0779b6ff0f6 GET /v1/drugs/d72f27a0-dbad-44f6-860a-c0779b6ff0f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki musujące",
"source": "urpl",
"strength": "-",
"packaging": "05909990202515 ¦ OTC ¦ 8864\n40 tabl.\nOTC ¦ Skasowane ¦ 8865\n80 tabl.",
"substance": "Natrii chloridum 121.5 mg + Natrii bromidium 0.045 mg + Kalii sulfas 6.03 mg + Natrii hydrogenocarbonas 318.15 mg + Natrii hydrophosphas 0.225 mg + Natrii sulfas 405 mg",
"common_name": "Preparat złożony",
"pl_product_id": "100059384",
"pozwolenie_nr": "02025",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about preparat złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.